## **Core Concept**
Stiff person syndrome (SPS) is a rare neurological disorder characterized by progressive stiffness and rigidity of the muscles, leading to impaired mobility and function. It is an autoimmune condition often associated with the presence of specific autoantibodies. The underlying pathophysiology involves an immune-mediated disruption of inhibitory neurotransmission.

## **Why the Correct Answer is Right**
The correct answer, **C. Anti-GAD antibodies**, is right because stiff person syndrome is strongly associated with the presence of autoantibodies against glutamic acid decarboxylase (GAD). GAD is an enzyme crucial for the synthesis of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). Autoantibodies against GAD disrupt GABAergic neurotransmission, leading to the clinical manifestations of SPS, including muscle stiffness, rigidity, and spasms.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while thyroid autoantibodies are associated with autoimmune thyroid diseases, they are not directly linked to the pathophysiology of stiff person syndrome.
- **Option B:** This option is incorrect as it does not specify a known autoantibody or pathogenic mechanism directly associated with SPS.
- **Option D:** This option is incorrect because while other autoantibodies might be present in various autoimmune conditions, they are not specifically or primarily associated with stiff person syndrome.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with stiff person syndrome often have **diabetes mellitus** due to the shared autoantibody target, GAD. This association highlights the importance of screening for autoimmune conditions in patients with SPS and vice versa.

## **Correct Answer:** . Anti-GAD antibodies